|
|
| Recherche Et Développement > Etude de marché sectorielle |
| Dyax Corp - SWOT Analysis |
|
|
|
|
€ 100,00 |
Editeur
: |
Datamonitor |
Langue
: |
Anglais |
Date de publication : |
Mars 2008 |
Taille du document : |
23 |
Autres informations : |
Description , Table des matières |
| |
|
|
|
|
| |
|
Rechercher d'autres rapports et études à commander
Rechercher et commander ici parmi 50.000 études de marché publiées par les principaux instituts d'études internationaux
|
| Rapports privés en relation |
|
Parsons Corporation - SWOT Analysis
20 pages | Juillet 2007 |
Datamonitor's Parsons Corporation - SWOT Analysis Company Profile is the essential source for top-level company data and information.
The report examines the company’s key business structure and op |
100,00 €
|
| |
| |
Canadian R&D Expenditures, 1984-2003
1 pages | Janvier 2006 |
This Database Table is a one-page table of hard-to-find numerical information.
The Database Table is derived from a proprietary source and is meant to simply provide a high-level overview of specif |
80,00 €
|
| |
| |
Enterprise Engineering Applications: global market forecast model (Interactive Model)
50 pages | Mai 2007 |
IntroductionThe Enterprise Engineering Applications interactive model offers the most comprehensive and up-to-date database of the software revenue opportunity for enterprise applications vendors.
|
1 516,00 €
|
| |
| |
Sandvik AB - SWOT Analysis
20 pages | Juillet 2007 |
Datamonitor's Sandvik AB - SWOT Analysis Company Profile is the essential source for top-level company data and information.
The report examines the company’s key business structure and operations, |
100,00 €
|
| |
| |
Supporting Product Development with Cutting Edge IT (Executive Presentation)
15 pages | Avril 2007 |
IntroductionProduct development in the manufacturing industry is changing dramatically.
This Executive Presentation gives an overview of what trends are occurring and how these trends are affecting |
1 516,00 €
|
| |
| |
Display Technology In India
35 pages | Novembre 2006 |
Display technology in the recent times has been undergoing a massive transformation, enabling design of innovative and elegant products and making existing products cheaper.
India has been contribu |
400,00 €
|
| |
| |
Dyax Corp - SWOT Analysis
22 pages | Mai 2007 |
Datamonitor's Dyax Corp - SWOT Analysis Company Profile is the essential source for top-level company data and information.
The report examines the company’s key business structure and operations, |
100,00 €
|
| |
| |
R&D Ratios & Budgets + statistics file
200 pages | Juin 2006 |
The detailed annual report covers 5,000+ companies and 280+ industries with information on past year R&D budgets, current year R&D-to-sales ratios and R&D-to-gross margin ratios, as well as current an |
390,00 €
|
| |
| |
Onyx Pharmaceuticals, Inc. - SWOT Analysis
26 pages | Mai 2007 |
Datamonitor's Onyx Pharmaceuticals, Inc.
- SWOT Analysis Company Profile is the essential source for top-level company data and information.
The report examines the company’s key business struct |
100,00 €
|
| |
| |
Engineering and construction services in France
15 pages | Septembre 2002 |
The French market for engineering and construction services has grown by 3.4% since 1999 to reach a value of FF246 billion (US$35 billion) in 2000.
Residential buildings form the largest sector, ac |
198,00 €
|
| |
| |
|
| |
| Autres secteurs en relation |
|
|
|
| |
|
| |
| |
| Présentation de l'étude de marché - Description & Table des matières |
|
| Dyax Corp - SWOT Analysis |
|
|
Datamonitor's Dyax Corp - SWOT Analysis Company Profile is the essential source for top-level company data and information. The report examines the company’s key business structure and operations, history and products, and provides summary analysis of its key revenue lines and strategy.
Dyax discovers, develops and commercializes biopharmaceuticals primarily in the areas of inflammation and oncology. The company, through its proprietary drug discovery technology, known as phage display, identifies antibody, small protein and peptide compounds for clinical development. The company is headquartered in Cambridge, Massachusetts and employed 161 people as of December 2006. *The company recorded revenues of $26.1 million during the fiscal year ended December 2007, as compared to $12.8 million in 2006. The operating loss of the company was $50.5 million during fiscal year 2007, as compared to the operating loss of $49.8 million in 2006. The net loss was $56.3 million in fiscal year 2007, as compared to the net loss of $50.3 million in 2006. *Unaudited results http://investor.dyax.com/phoenix.zhtml?c=122200&p=irol-newsArticle&ID=1112869&highlight=
Scope of the Report
- Provides all the crucial company information required for business and competitor intelligence needs
- Contains a study of the major internal and external factors affecting the company in the form of a SWOT analysis as well as a breakdown and examination of leading product revenue streams
- Data is supplemented with details on the company’s history, key executives, business description, locations and subsidiaries as well as a list of products and services and the latest available company statement
Reasons to Purchase
- Support sales activities by understanding your customers’ businesses better
- Qualify prospective partners and suppliers
- Keep fully up to date on your competitors’ business structure, strategy and prospects
- Obtain the most up to date company information available
|
|
Table of Contents:
This product typically includes the following sections:
Key Facts
Company Overview
Business Description
Company History
Key Employees
Key Employee Biographies
Company View
SWOT analysis
Products & Services Listing
Products & Services Analysis
|
|
|
PPLSEN
|
|
|
|
|
